News

10 August 2023

#

Challenges in comparing breaking force test results.

Two measurement principles are described in the US Pharmacopeia <1217>: Constant speed ≤ 3.5mm/s or linear force ≤ 20N/s. But comparability is only guaranteed when tests are performed under identical conditions.

read more

27 July 2023

#

Catching the sun over Aesch, Switzerland.

SOTAX is becoming more sustainable – thanks to the new photovoltaic system at its headquarters.

read more

20 July 2023

#

Accelerated In-Vitro Release?

Establishing an in-vitro / in-vivo correlation is challenging in the development and testing of pharmaceutical formulations. A discrepancy leads to difficulties in accurately predicting how the formulation will behave and perform in the human body.

read more

17 July 2023

#

Xtend™: Export PDF reports to USB flash drive or to the EasyTouch™ file share

When operating your Xtend™ dissolution system without q-doc® or WinSOTAX® plus, you can also export reports as PDF.

read more

29 June 2023

#

We are SOTAX – since 1973.

The heart of every company is its employees and their contributions. Today, we want to introduce you to just a few of the faces worldwide who make up the SOTAX brand.

read more

22 June 2023

#

Are you working with complex dosage forms?

Emerging formulations and novel drug delivery technologies require a revised approach to in-vitro drug release testing. Due to the complex nature of these formulations, extensive testing and development are crucial to ensure patient safety and efficacy.

read more

25 May 2023

#

q-doc® – New version 4L available now.

From configurable process drivers to the integration of new testing instruments – the latest software version offers a whole package of new features to make your IPC processes easier and more compliant.

read more

08 May 2023

#

We love Dissolution.

At SOTAX, we are proud of our 50-year history of innovating dissolution testing. Time to celebrate our passion and to show you dissolving tablets like you have never seen them before.

read more

01 May 2023

#

New Standard for Dissolution Performance Verification Test (PVT)

On 01 May 2023, the United States Pharmacopeia (USP) has introduced a new formulation of their prednisone tablets. Make sure to use this new 'Dissolution Performance Verification Standard' (DPVS) for your performance verification tests (PVT).

read more

03 April 2023

#

Successful re-certification according to ISO 9001:2015.

We are happy to announce that SOTAX has been successully audited according to ISO 9001:2015 certification of quality management systems. After having recently added new SOTAX sites to our organization, we proud of our re-certified global quality system.

read more